课题基金 / 基金详情

Glucocorticoids or Avacopan in peopLe with high-risk renal Anti-Neutrophil cytoplasm antibody associated vasculitis Trial (GALANT) - Pilot

Glucocorticoids or Avacopan in peopLe with high-risk renal Anti-Neutrophil cytoplasm antibody associated vasculitis Trial (GALANT) - Pilot
糖皮质激素或 Avacopan 用于高危肾病患者抗中性粒细胞胞质抗体相关性血管炎试验 (GALANT) - 试点
批准号:
489796
负责人:
Walsh Michael W
金额:
$37.9万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-09-01 至 2027-03-01

项目摘要

项目成果

Walsh Michael W的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Anti-neutrophil cytoplasm antibody associated vasculitis, or AAV, is an uncommon disease affecting approximately 10,000 Canadians. AAV can affect any organ in the body by inflaming blood vessels. Before effective treatments were available, 90% of patients
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aldosterone blockade for Health Improvement Evaluation in End-stage kidney disease: Extension
  • 批准号:
    461992
  • 项目类别:
    Operating Grants
  • 资助金额:
    $88.05万
  • 财政年份:
    2022
  • 负责人:
    Walsh Michael W
  • 依托单位:
Protection of the heart with aldosterone antagonism in end-stage renal disease (PHASE 2) Trial
  • 批准号:
    333015
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2015
  • 负责人:
    Walsh Michael W
  • 依托单位:
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: extended follow-up of a randomized controlled trial
  • 批准号:
    322606
  • 项目类别:
    Operating Grants
  • 资助金额:
    $24.76万
  • 财政年份:
    2015
  • 负责人:
    Walsh Michael W
  • 依托单位:
Protection of the heart with aldosterone antagonism in end-stage renal disease (PHASE 2) Trial
  • 批准号:
    310286
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2014
  • 负责人:
    Walsh Michael W
  • 依托单位:
海外基金